Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 925 to 936 of 948 entries
Sorted by: Best Match Show Resources per page
Cancer Mortality Rates Increasing vs Cardiovascular Disease Mortality Decreasing in the World: Future Implications.

Mayo Clinic proceedings. Innovations, quality & outcomes

ReFaey K, Tripathi S, Grewal SS, Bhargav AG, Quinones DJ, Chaichana KL, Antwi SO, Cooper LT, Meyer FB, Dronca RS, Diasio RB, Quinones-Hinojosa A.
PMID: 34195556
Mayo Clin Proc Innov Qual Outcomes. 2021 Jun 08;5(3):645-653. doi: 10.1016/j.mayocpiqo.2021.05.005. eCollection 2021 Jun.

OBJECTIVE: To highlight the current global trends in mortality for cardiovascular disease and cancer.METHODS: The World Health Organization and the World Bank DataBank databases were used to analyze mortality rates for cancer and cardiovascular disease by calculating age-standardized mortality...

Cite
ReFaey K, Tripathi S, Grewal SS, et al. Cancer Mortality Rates Increasing vs Cardiovascular Disease Mortality Decreasing in the World: Future Implications. Mayo Clin Proc Innov Qual Outcomes. 2021;5(3):645-653doi: 10.1016/j.mayocpiqo.2021.05.005.
ReFaey, K., Tripathi, S., Grewal, S. S., Bhargav, A. G., Quinones, D. J., Chaichana, K. L., Antwi, S. O., Cooper, L. T., Meyer, F. B., Dronca, R. S., Diasio, R. B., & Quinones-Hinojosa, A. (2021). Cancer Mortality Rates Increasing vs Cardiovascular Disease Mortality Decreasing in the World: Future Implications. Mayo Clinic proceedings. Innovations, quality & outcomes, 5(3), 645-653. https://doi.org/10.1016/j.mayocpiqo.2021.05.005
ReFaey, Karim, et al. "Cancer Mortality Rates Increasing vs Cardiovascular Disease Mortality Decreasing in the World: Future Implications." Mayo Clinic proceedings. Innovations, quality & outcomes vol. 5,3 (2021): 645-653. doi: https://doi.org/10.1016/j.mayocpiqo.2021.05.005
ReFaey K, Tripathi S, Grewal SS, Bhargav AG, Quinones DJ, Chaichana KL, Antwi SO, Cooper LT, Meyer FB, Dronca RS, Diasio RB, Quinones-Hinojosa A. Cancer Mortality Rates Increasing vs Cardiovascular Disease Mortality Decreasing in the World: Future Implications. Mayo Clin Proc Innov Qual Outcomes. 2021 Jun 08;5(3):645-653. doi: 10.1016/j.mayocpiqo.2021.05.005. eCollection 2021 Jun. PMID: 34195556; PMCID: PMC8240359.
Copy Download .nbib Format: NLM
In the Limelight: June 2021.

Mayo Clinic proceedings

Nath KA.
PMID: 34088407
Mayo Clin Proc. 2021 Jun;96(6):1383-1386. doi: 10.1016/j.mayocp.2021.04.018.

No abstract available.

Cite
Nath KA. In the Limelight: June 2021. Mayo Clin Proc. 2021;96(6):1383-1386doi: 10.1016/j.mayocp.2021.04.018.
Nath, K. A. (2021). In the Limelight: June 2021. Mayo Clinic proceedings, 96(6), 1383-1386. https://doi.org/10.1016/j.mayocp.2021.04.018
Nath, Karl A. "In the Limelight: June 2021." Mayo Clinic proceedings vol. 96,6 (2021): 1383-1386. doi: https://doi.org/10.1016/j.mayocp.2021.04.018
Nath KA. In the Limelight: June 2021. Mayo Clin Proc. 2021 Jun;96(6):1383-1386. doi: 10.1016/j.mayocp.2021.04.018. PMID: 34088407.
Copy Download .nbib Format: NLM
Thyroid Abscess Associated With Pyriform Sinus Fistula.

Mayo Clinic proceedings

Wang WC, Shen HN.
PMID: 34736611
Mayo Clin Proc. 2021 Nov;96(11):2854-2855. doi: 10.1016/j.mayocp.2021.08.023.

No abstract available.

Cite
Wang WC, Shen HN. Thyroid Abscess Associated With Pyriform Sinus Fistula. Mayo Clin Proc. 2021;96(11):2854-2855doi: 10.1016/j.mayocp.2021.08.023.
Wang, W. C., & Shen, H. N. (2021). Thyroid Abscess Associated With Pyriform Sinus Fistula. Mayo Clinic proceedings, 96(11), 2854-2855. https://doi.org/10.1016/j.mayocp.2021.08.023
Wang, Wen-Ching, and Shen, Hsiu-Nien. "Thyroid Abscess Associated With Pyriform Sinus Fistula." Mayo Clinic proceedings vol. 96,11 (2021): 2854-2855. doi: https://doi.org/10.1016/j.mayocp.2021.08.023
Wang WC, Shen HN. Thyroid Abscess Associated With Pyriform Sinus Fistula. Mayo Clin Proc. 2021 Nov;96(11):2854-2855. doi: 10.1016/j.mayocp.2021.08.023. PMID: 34736611.
Copy Download .nbib Format: NLM
The Renin-Angiotensin-Aldosterone System in Postmenopausal Women: The Promise of Hormone Therapy.

Mayo Clinic proceedings

Gersh FL, O'Keefe JH, Lavie CJ, Henry BM.
PMID: 34736778
Mayo Clin Proc. 2021 Dec;96(12):3130-3141. doi: 10.1016/j.mayocp.2021.08.009. Epub 2021 Nov 02.

Estradiol (E2) plays an underrecognized role in modulating body-wide systems, including important interactions with the renin-angiotensin-aldosterone system (RAAS). The RAAS is an immunomodulating system that is critical for maintaining homeostasis across multiple organ systems. The diverse interactions between E2...

Cite
Gersh FL, O'Keefe JH, Lavie CJ, et al. The Renin-Angiotensin-Aldosterone System in Postmenopausal Women: The Promise of Hormone Therapy. Mayo Clin Proc. 2021;96(12):3130-3141doi: 10.1016/j.mayocp.2021.08.009.
Gersh, F. L., O'Keefe, J. H., Lavie, C. J., & Henry, B. M. (2021). The Renin-Angiotensin-Aldosterone System in Postmenopausal Women: The Promise of Hormone Therapy. Mayo Clinic proceedings, 96(12), 3130-3141. https://doi.org/10.1016/j.mayocp.2021.08.009
Gersh, Felice L, et al. "The Renin-Angiotensin-Aldosterone System in Postmenopausal Women: The Promise of Hormone Therapy." Mayo Clinic proceedings vol. 96,12 (2021): 3130-3141. doi: https://doi.org/10.1016/j.mayocp.2021.08.009
Gersh FL, O'Keefe JH, Lavie CJ, Henry BM. The Renin-Angiotensin-Aldosterone System in Postmenopausal Women: The Promise of Hormone Therapy. Mayo Clin Proc. 2021 Dec;96(12):3130-3141. doi: 10.1016/j.mayocp.2021.08.009. Epub 2021 Nov 02. PMID: 34736778.
Copy Download .nbib Format: NLM
91-Year-Old Man With Recurrent Falls.

Mayo Clinic proceedings

Bogin MH, Verdoorn BP.
PMID: 34736779
Mayo Clin Proc. 2021 Dec;96(12):3153-3157. doi: 10.1016/j.mayocp.2021.03.041. Epub 2021 Nov 02.

No abstract available.

Cite
Bogin MH, Verdoorn BP. 91-Year-Old Man With Recurrent Falls. Mayo Clin Proc. 2021;96(12):3153-3157doi: 10.1016/j.mayocp.2021.03.041.
Bogin, M. H., & Verdoorn, B. P. (2021). 91-Year-Old Man With Recurrent Falls. Mayo Clinic proceedings, 96(12), 3153-3157. https://doi.org/10.1016/j.mayocp.2021.03.041
Bogin, Melissa H, and Verdoorn, Brandon P. "91-Year-Old Man With Recurrent Falls." Mayo Clinic proceedings vol. 96,12 (2021): 3153-3157. doi: https://doi.org/10.1016/j.mayocp.2021.03.041
Bogin MH, Verdoorn BP. 91-Year-Old Man With Recurrent Falls. Mayo Clin Proc. 2021 Dec;96(12):3153-3157. doi: 10.1016/j.mayocp.2021.03.041. Epub 2021 Nov 02. PMID: 34736779.
Copy Download .nbib Format: NLM
Research Involving Participants With Impaired Consent Capacity: An Examination of Methods to Determine Capacity to Consent.

Mayo Clinic proceedings

Lapid MI, Clarke BL, Ho JB, Ouellette Y, Armbrust TL, Wright RS.
PMID: 34736608
Mayo Clin Proc. 2021 Nov;96(11):2806-2822. doi: 10.1016/j.mayocp.2021.04.029.

OBJECTIVE: To examine methods of assessing consent capacity in research protocols involving participants with impaired consent capacity, and examine instruments used to evaluate research consent capacity.METHODS: A retrospective review of 330 active research protocols involving participants lacking capacity to...

Cite
Lapid MI, Clarke BL, Ho JB, et al. Research Involving Participants With Impaired Consent Capacity: An Examination of Methods to Determine Capacity to Consent. Mayo Clin Proc. 2021;96(11):2806-2822doi: 10.1016/j.mayocp.2021.04.029.
Lapid, M. I., Clarke, B. L., Ho, J. B., Ouellette, Y., Armbrust, T. L., & Wright, R. S. (2021). Research Involving Participants With Impaired Consent Capacity: An Examination of Methods to Determine Capacity to Consent. Mayo Clinic proceedings, 96(11), 2806-2822. https://doi.org/10.1016/j.mayocp.2021.04.029
Lapid, Maria I, et al. "Research Involving Participants With Impaired Consent Capacity: An Examination of Methods to Determine Capacity to Consent." Mayo Clinic proceedings vol. 96,11 (2021): 2806-2822. doi: https://doi.org/10.1016/j.mayocp.2021.04.029
Lapid MI, Clarke BL, Ho JB, Ouellette Y, Armbrust TL, Wright RS. Research Involving Participants With Impaired Consent Capacity: An Examination of Methods to Determine Capacity to Consent. Mayo Clin Proc. 2021 Nov;96(11):2806-2822. doi: 10.1016/j.mayocp.2021.04.029. PMID: 34736608.
Copy Download .nbib Format: NLM
Creation of a Multispecialty Clinic for Patients with Central Sensitization-Based Chronic Pain Conditions.

Mayo Clinic proceedings. Innovations, quality & outcomes

Loftus CG, Ebbert JO, Aakre CA, Caine NA, DeZutter MA, Eastman RJ, Fischer SM, Gilman EA, Johnson MG, Luedtke CA, Mohabbat AB, Reinschmidt KJ, Roellinger DL, Sanchez W, Philpot LM.
PMID: 35005437
Mayo Clin Proc Innov Qual Outcomes. 2021 Dec 23;6(1):45-54. doi: 10.1016/j.mayocpiqo.2021.11.003. eCollection 2022 Feb.

OBJECTIVE: To design and evaluate, through a human-centered design approach, a multispeciality clinic for patients with central sensitization syndromes that combined virtual previsit consultations, traditional face-to-face appointments, and technology-enabled educational programming.PATIENTS AND METHODS: Patients with suspected fibromyalgia and chronic...

Cite
Loftus CG, Ebbert JO, Aakre CA, et al. Creation of a Multispecialty Clinic for Patients with Central Sensitization-Based Chronic Pain Conditions. Mayo Clin Proc Innov Qual Outcomes. 2021;6(1):45-54doi: 10.1016/j.mayocpiqo.2021.11.003.
Loftus, C. G., Ebbert, J. O., Aakre, C. A., Caine, N. A., DeZutter, M. A., Eastman, R. J., Fischer, S. M., Gilman, E. A., Johnson, M. G., Luedtke, C. A., Mohabbat, A. B., Reinschmidt, K. J., Roellinger, D. L., Sanchez, W., & Philpot, L. M. (2022). Creation of a Multispecialty Clinic for Patients with Central Sensitization-Based Chronic Pain Conditions. Mayo Clinic proceedings. Innovations, quality & outcomes, 6(1), 45-54. https://doi.org/10.1016/j.mayocpiqo.2021.11.003
Loftus, Conor G, et al. "Creation of a Multispecialty Clinic for Patients with Central Sensitization-Based Chronic Pain Conditions." Mayo Clinic proceedings. Innovations, quality & outcomes vol. 6,1 (2022): 45-54. doi: https://doi.org/10.1016/j.mayocpiqo.2021.11.003
Loftus CG, Ebbert JO, Aakre CA, Caine NA, DeZutter MA, Eastman RJ, Fischer SM, Gilman EA, Johnson MG, Luedtke CA, Mohabbat AB, Reinschmidt KJ, Roellinger DL, Sanchez W, Philpot LM. Creation of a Multispecialty Clinic for Patients with Central Sensitization-Based Chronic Pain Conditions. Mayo Clin Proc Innov Qual Outcomes. 2021 Dec 23;6(1):45-54. doi: 10.1016/j.mayocpiqo.2021.11.003. eCollection 2022 Feb. PMID: 35005437; PMCID: PMC8715289.
Copy Download .nbib Format: NLM
Physical and Mental Health Comorbidities Among Adults With Multiple Sclerosis.

Mayo Clinic proceedings. Innovations, quality & outcomes

Peterson MD, Lin P, Kamdar N, Marsack-Topolewski CN, Mahmoudi E.
PMID: 35005438
Mayo Clin Proc Innov Qual Outcomes. 2021 Dec 23;6(1):55-68. doi: 10.1016/j.mayocpiqo.2021.11.004. eCollection 2022 Feb.

OBJECTIVE: To compare the incidence of and adjusted hazard ratios for common cardiometabolic diseases, musculoskeletal disorders, and psychological morbidities among adults with and without multiple sclerosis (MS).PATIENTS AND METHODS: Beneficiaries were included if they had an RESULTS: Adults with...

Cite
Peterson MD, Lin P, Kamdar N, et al. Physical and Mental Health Comorbidities Among Adults With Multiple Sclerosis. Mayo Clin Proc Innov Qual Outcomes. 2021;6(1):55-68doi: 10.1016/j.mayocpiqo.2021.11.004.
Peterson, M. D., Lin, P., Kamdar, N., Marsack-Topolewski, C. N., & Mahmoudi, E. (2022). Physical and Mental Health Comorbidities Among Adults With Multiple Sclerosis. Mayo Clinic proceedings. Innovations, quality & outcomes, 6(1), 55-68. https://doi.org/10.1016/j.mayocpiqo.2021.11.004
Peterson, Mark D, et al. "Physical and Mental Health Comorbidities Among Adults With Multiple Sclerosis." Mayo Clinic proceedings. Innovations, quality & outcomes vol. 6,1 (2022): 55-68. doi: https://doi.org/10.1016/j.mayocpiqo.2021.11.004
Peterson MD, Lin P, Kamdar N, Marsack-Topolewski CN, Mahmoudi E. Physical and Mental Health Comorbidities Among Adults With Multiple Sclerosis. Mayo Clin Proc Innov Qual Outcomes. 2021 Dec 23;6(1):55-68. doi: 10.1016/j.mayocpiqo.2021.11.004. eCollection 2022 Feb. PMID: 35005438; PMCID: PMC8715377.
Copy Download .nbib Format: NLM
Treatment of Obesity: Pharmacotherapy Trends of Office-Based Visits in the United States From 2011 to 2016.

Mayo Clinic proceedings

Claridy MD, Czepiel KS, Bajaj SS, Stanford FC.
PMID: 34728060
Mayo Clin Proc. 2021 Dec;96(12):2991-3000. doi: 10.1016/j.mayocp.2021.07.021. Epub 2021 Oct 30.

OBJECTIVE: To examine pharmacotherapy for obesity in the United States from 2011 to 2016 using a large, nationally representative sample.METHODS: Data were obtained during 6 years, 2011 to 2016, from the National Ambulatory Medical Care Survey. There were 3...

Cite
Claridy MD, Czepiel KS, Bajaj SS, et al. Treatment of Obesity: Pharmacotherapy Trends of Office-Based Visits in the United States From 2011 to 2016. Mayo Clin Proc. 2021;96(12):2991-3000doi: 10.1016/j.mayocp.2021.07.021.
Claridy, M. D., Czepiel, K. S., Bajaj, S. S., & Stanford, F. C. (2021). Treatment of Obesity: Pharmacotherapy Trends of Office-Based Visits in the United States From 2011 to 2016. Mayo Clinic proceedings, 96(12), 2991-3000. https://doi.org/10.1016/j.mayocp.2021.07.021
Claridy, Mechelle D, et al. "Treatment of Obesity: Pharmacotherapy Trends of Office-Based Visits in the United States From 2011 to 2016." Mayo Clinic proceedings vol. 96,12 (2021): 2991-3000. doi: https://doi.org/10.1016/j.mayocp.2021.07.021
Claridy MD, Czepiel KS, Bajaj SS, Stanford FC. Treatment of Obesity: Pharmacotherapy Trends of Office-Based Visits in the United States From 2011 to 2016. Mayo Clin Proc. 2021 Dec;96(12):2991-3000. doi: 10.1016/j.mayocp.2021.07.021. Epub 2021 Oct 30. PMID: 34728060; PMCID: PMC8649050.
Copy Download .nbib Format: NLM
Rhinorbitocerebral Mucormycosis in Uncontrolled Diabetes.

Mayo Clinic proceedings

Grach SL, Yetmar ZA, Rowan DJ, DeSimone DC.
PMID: 34607635
Mayo Clin Proc. 2021 Oct;96(10):2651-2652. doi: 10.1016/j.mayocp.2021.06.008.

No abstract available.

Cite
Grach SL, Yetmar ZA, Rowan DJ, et al. Rhinorbitocerebral Mucormycosis in Uncontrolled Diabetes. Mayo Clin Proc. 2021;96(10):2651-2652doi: 10.1016/j.mayocp.2021.06.008.
Grach, S. L., Yetmar, Z. A., Rowan, D. J., & DeSimone, D. C. (2021). Rhinorbitocerebral Mucormycosis in Uncontrolled Diabetes. Mayo Clinic proceedings, 96(10), 2651-2652. https://doi.org/10.1016/j.mayocp.2021.06.008
Grach, Stephanie L, et al. "Rhinorbitocerebral Mucormycosis in Uncontrolled Diabetes." Mayo Clinic proceedings vol. 96,10 (2021): 2651-2652. doi: https://doi.org/10.1016/j.mayocp.2021.06.008
Grach SL, Yetmar ZA, Rowan DJ, DeSimone DC. Rhinorbitocerebral Mucormycosis in Uncontrolled Diabetes. Mayo Clin Proc. 2021 Oct;96(10):2651-2652. doi: 10.1016/j.mayocp.2021.06.008. PMID: 34607635.
Copy Download .nbib Format: NLM
Medical Cannabis State and Federal Regulations: Implications for United States Health Care Entities.

Mayo Clinic proceedings

Perlman AI, McLeod HM, Ventresca EC, Salinas MG, Post PJ, Schuh MJ, Abu Dabrh AM.
PMID: 34607636
Mayo Clin Proc. 2021 Oct;96(10):2671-2681. doi: 10.1016/j.mayocp.2021.05.005.

Thirty-six states and four territories in the United States have legalized cannabis for medical and/or recreational use. Marijuana, however, continues to be classified as a schedule I substance under the Federal Controlled Substance Act and remains illegal under US...

Cite
Perlman AI, McLeod HM, Ventresca EC, et al. Medical Cannabis State and Federal Regulations: Implications for United States Health Care Entities. Mayo Clin Proc. 2021;96(10):2671-2681doi: 10.1016/j.mayocp.2021.05.005.
Perlman, A. I., McLeod, H. M., Ventresca, E. C., Salinas, M. G., Post, P. J., Schuh, M. J., & Abu Dabrh, A. M. (2021). Medical Cannabis State and Federal Regulations: Implications for United States Health Care Entities. Mayo Clinic proceedings, 96(10), 2671-2681. https://doi.org/10.1016/j.mayocp.2021.05.005
Perlman, Adam I, et al. "Medical Cannabis State and Federal Regulations: Implications for United States Health Care Entities." Mayo Clinic proceedings vol. 96,10 (2021): 2671-2681. doi: https://doi.org/10.1016/j.mayocp.2021.05.005
Perlman AI, McLeod HM, Ventresca EC, Salinas MG, Post PJ, Schuh MJ, Abu Dabrh AM. Medical Cannabis State and Federal Regulations: Implications for United States Health Care Entities. Mayo Clin Proc. 2021 Oct;96(10):2671-2681. doi: 10.1016/j.mayocp.2021.05.005. PMID: 34607636.
Copy Download .nbib Format: NLM
Safe Triage of STEMI Patients to General Telemetry Units After Successful Primary Percutaneous Coronary Intervention.

Mayo Clinic proceedings. Innovations, quality & outcomes

Nan JZ, Jentzer JC, Ward RC, Le RJ, Prasad M, Barsness GW, Gulati R, Sandhu GS, Bell MR.
PMID: 34877476
Mayo Clin Proc Innov Qual Outcomes. 2021 Nov 26;5(6):1118-1127. doi: 10.1016/j.mayocpiqo.2021.09.009. eCollection 2021 Dec.

OBJECTIVE: To analyze outcomes of patients with ST-segment elevation myocardial infarction (STEMI) after successful primary percutaneous coronary intervention (PCI) triaged to the cardiac intensive care unit (CICU) vs a general telemetry unit by a Zwolle risk score-based algorithm.METHODS: We...

Cite
Nan JZ, Jentzer JC, Ward RC, et al. Safe Triage of STEMI Patients to General Telemetry Units After Successful Primary Percutaneous Coronary Intervention. Mayo Clin Proc Innov Qual Outcomes. 2021;5(6):1118-1127doi: 10.1016/j.mayocpiqo.2021.09.009.
Nan, J. Z., Jentzer, J. C., Ward, R. C., Le, R. J., Prasad, M., Barsness, G. W., Gulati, R., Sandhu, G. S., & Bell, M. R. (2021). Safe Triage of STEMI Patients to General Telemetry Units After Successful Primary Percutaneous Coronary Intervention. Mayo Clinic proceedings. Innovations, quality & outcomes, 5(6), 1118-1127. https://doi.org/10.1016/j.mayocpiqo.2021.09.009
Nan, John Z, et al. "Safe Triage of STEMI Patients to General Telemetry Units After Successful Primary Percutaneous Coronary Intervention." Mayo Clinic proceedings. Innovations, quality & outcomes vol. 5,6 (2021): 1118-1127. doi: https://doi.org/10.1016/j.mayocpiqo.2021.09.009
Nan JZ, Jentzer JC, Ward RC, Le RJ, Prasad M, Barsness GW, Gulati R, Sandhu GS, Bell MR. Safe Triage of STEMI Patients to General Telemetry Units After Successful Primary Percutaneous Coronary Intervention. Mayo Clin Proc Innov Qual Outcomes. 2021 Nov 26;5(6):1118-1127. doi: 10.1016/j.mayocpiqo.2021.09.009. eCollection 2021 Dec. PMID: 34877476; PMCID: PMC8633820.
Copy Download .nbib Format: NLM
Showing 925 to 936 of 948 entries